
Additive effect of simultaneous continuous administration of degarelix and TAK-448 on LH suppression in a castrated rat model
Keywords: آنتاگونیست هورمون آزاد کننده گنادوتروپین; Degarelix (PubChem CID: 16136245); TAK-448 (PubChem CID: 46700761); Prostate cancer; Androgen deprivation therapy; Testosterone; Gonadotropin-releasing hormone antagonist; Kisspeptin analog; Drug combination;